Upgrade to SI Premium - Free Trial

Brainstorm Cell Therapeutics (BCLI) Files $200M Mixed Shelf

August 9, 2021 5:00 PM

Brainstorm Cell Therapeutics (NASDAQ: BCLI) files $200,000,000 mixed shelf.

Categories

Corporate News Equity Offerings

Next Articles